1365803-52-6CC#CCOc1ccc(S(=O)(=O)CC(c2ccc(CNS(C)(=O)=O)cc2)N(O)C=O)cc1VIWDSTUVCAZZDF-UHFFFAOYSA-N1365803-52-6Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
VerwendenN-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide was used to study components containing ADAM17-inhibiting N-hydroxyformamide derivatives for maintaining platelet functions in cultures. The compound was also used in the study to prepare N-hydrooxyformamides as ADAM inhibitors for treatment of various diseases.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…